Research in social & administrative pharmacy : RSAP
-
Res Social Adm Pharm · May 2013
ReviewEconomic, clinical, and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: a literature review.
The U.S. population of racial/ethnic minorities continues to increase; however, health disparities and poor health outcomes among many of them continue to be a major public health problem confronting the U.S. health care system. ⋯ This review shows that there is a positive relationship between pharmaceutical care and ECHOs in patients from racial/ethnic minority groups. However, more studies are needed to document the effects of pharmaceutical care on reducing racial/ethnic health disparities and to determine which interventions are most effective among certain groups with health disparities.
-
Res Social Adm Pharm · May 2013
Determinants of nonmedical use, abuse or dependence on prescription drugs, and use of substance abuse treatment.
Previous studies have found a negative association between health insurance and nonmedical use of prescription drugs (NMUPD), and abuse or dependence on prescription drugs (ADPD); and mixed associations between health insurance and use of substance abuse treatment (SAT). However, effect of health insurance in the specific subgroups of population is largely unknown. ⋯ Health insurance had a differential impact on NMUPD only. Among privately insured, Hispanics and individuals reporting family income less than $20,000 were more likely to engage in NMUPD. There is a need to better understand and monitor the use of prescription drugs among these groups. This knowledge can help in developing public health programs and policies that discourage NMUPD among these individuals.
-
Res Social Adm Pharm · May 2013
Working in interprofessional primary health care teams: what do pharmacists do?
Interprofessional teams are forming in primary health care. Little is known about how health care professional roles and routines develop in this environment. ⋯ Pharmacist routines and their own perception of their roles differed across interprofessional teams. Differences could be attributed to different educational background, philosophy of practice or characteristics of individual pharmacists, and also affected by leadership and communication within family health teams (FHTs). FHT leaders wanting to include a pharmacist to improve medication therapy should demonstrate leadership and vision by articulating needs and hiring a pharmacist with matching knowledge, skills, and qualities. A similar, generic approach may be useful to determine the need for and roles of any health care professional joining the team.
-
Res Social Adm Pharm · Mar 2013
ReviewEnsuring continuing fitness to practice in the pharmacy workforce: Understanding the challenges of revalidation.
Revalidation is about assuring that health practitioners remain up to date and fit to practice, and demonstrating that they continue to meet the requirements of their professional regulator. ⋯ To ensure proportionality, it must be considered whether the same standards and/or sources of evidence should apply to all pharmacy professionals, either dependent on whether they are patient facing, their scope of practice, or whether Phs and PTs should be treated differently.
-
Res Social Adm Pharm · Mar 2013
Pharmacists' and pharmacy technicians' views on a process of revalidation of pharmacy professionals in Great Britain.
Revalidation will be introduced for pharmacy professionals in Great Britain. However, what pharmacists and technicians understand about it as a process remains unexplored. ⋯ Pharmacists and technicians do not share the same views on all aspects of revalidation, suggesting that 1 single model may not be desirable or practicable. Both groups identified CPD, appraisal, and feedback from peers as possible components of revalidation, but concerns about impartiality and independence of assessors were raised.